However, we found that high Wnt2B expression subgroup has fewer AML‐M4 patients, whereas high Wnt10A expression subgroup has more AML‐M4 patients in the chemotherapy group, suggesting that different Wnt genes may be selectively expressed in different AML subtypes. This evidence concerns the gene WNT10A and acute myeloid leukemia.